ERBB2 and breast carcinoma: Our findings are in agreement with previous studies, showing that the presence of HER2-positive CTCs co-expressing a breast cancer stem cell profile (HER2+/CD44+/CD24(low)) and elevated ALDH1 activity is related to aggressiveness and radioresistance [50].